US 11648318
Anti-transferrin receptor (TFR) antibody and uses thereof
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11648318 (Anti-transferrin receptor (TFR) antibody and uses thereof) held by Dyne Therapeutics, Inc. expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K47/6807